To investigate the possible signaling pathways underlying the resistance of HCC cells to Lexa, we used the specific inhibitors NBD, PD98059, SB203580, and SP600125 to respectively inhibit the IKK, MAPK, P38, and JNK signaling pathways. Here, MAPK8 is linked to hepatocellular carcinoma.